RESILIENCE helps you survive cancer with a strong heart

Clinical Practice Guidelines of Cardio-Oncology

The new Clinical Practice Guidelines of Cardio-Oncology were released in August 2022. RESILIENCE is proud to count with two relevant members of the Task Force as project investigators. Teresa López-Fernández is the Chairperson of this Clinical Practice Guideline and co-Principal investigator of European Society of Cardiology (ESC) in RESILIENCE project. Raúl Córdoba is the Principal Investigator (PI) of IISD-FJD for RESILIENCE project and was the haematologist participating in the document.

The 2022 European Society of Cardiology Guidelines of Cardio-Oncology is a collaborative project with the participation of the European Hematology Association (EHA). Patients with haematological malignancies suffer from many cardiovascular adverse events and they need the specialized health care provided by a cardiologist with expertise in cardio-oncology. The key points of these guidelines to be followed by haematologists are:

  • The document provides standard definitions for cancer therapy–related cardiotoxicity, guidance on baseline risk assessment, and protocols for surveillance of cardiotoxicity during and after cancer treatment.
  • Cardio-oncology providers must have a broad knowledge of cardiology, oncology and hematology, with interdisciplinary communication in a multidisciplinary approach to care.
  • A guiding principle of the practice of cardio-oncology is to minimize unnecessary cancer therapy interruptions, with the decision to do so based on multidisciplinary discussions.
  • Echocardiography and blood-based cardiac biomarkers are the recommended methods used in the assessment and monitoring of cardiotoxicity.
Logotipo Resilience

Are you a patient participating in RESILIENCE? Here you will find useful information about the details of your participation, activities specifically designed for you. You will also be able to contact RESILIENCE researchers.

In accordance with the provisions of Regulation (EU) 2016/679 on the protection of personal data of natural persons (GDPR), the personal information you have provided will be incorporated into the data processing systems of the Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) for the purpose of attending your registration application in the restricted area for patients participating in the RESILIENCE study. The legal basis for processing your personal data for this purpose is your explicit consent. Your personal data will not be disclosed to any recipients other than those to whom you authorise or when required by law to do so. You may exercise your rights of access, right to rectification, to object, to erasure, to restriction of processing, data portability and not to be subject to automated individual decision-making. To exercise these rights, as well as to obtain additional information about the processing of your personal data, you can consult the following link Terms and Conditions